Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 12, 2026
Substrate-Selective Inhibition of the SARS-CoV-2 Papain-Like Protease: Inhibition of Hydrolysis of Human Over Viral SubstratesSakshi Sharma, Peter A C Wing, Wojtek Trede, et al.Bulletin of the Chemical Society of Japan|June 3, 2024
Cyclic β2,3-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main proteaseTakashi Miura, Tika R Malla, Lennart Brewitz, et al.Biochimie|March 22, 2021
Structure and activation mechanism of the human liver-type glutaminase GLS2Igor M Ferreira, José Edwin N Quesñay, Alliny Cs Bastos, et al.Chemical Communications (Cambridge, England)|January 19, 2021
Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 Mpro inhibitorsTika R Malla, Anthony Tumber, Tobias John, et al.Essays in Biochemistry|November 10, 2017
The SGC beyond structural genomics: redefining the role of 3D structures by coupling genomic stratification with fragment-based discoveryAnthony R Bradley, Aude Echalier, Michael Fairhead, et al.Nature Chemistry|May 22, 2023
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ2,4-amino acids targeting the SARS-CoV-2 main proteaseTakashi Miura, Tika R Malla, C David Owen, et al.Cell Chemical Biology|June 26, 2021
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitorDaniel Zaidman, Paul Gehrtz, Mihajlo Filep, et al.Journal of Medicinal Chemistry|February 9, 2023
Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic CysteineLennart Brewitz, Leo Dumjahn, Yilin Zhao, et al.Science Advances|June 21, 2023
Accelerating drug target inhibitor discovery with a deep generative foundation modelVijil Chenthamarakshan, Samuel C Hoffman, C David Owen, et al.Journal of Chemical Information and Modeling|April 14, 2023
AI-Driven Discovery of SARS-CoV-2 Main Protease Fragment-like Inhibitors with Antiviral Activity In VitroLuiz Carlos Saramago, Marcos V Santana, Bárbara Figueira Gomes, et al.Pageof 4